As more investigational drugs become available vs COVID19, is it time for PH to buy?
Watch more on iWantTFC MANILA— Government's adviser for COVID-19 response on Saturday said more studies are needed before the country could procure investigational drugs for treatment, noting that it is only available through compassionate permits.
In a public briefing, Dr. Ted Herbosa pointed out that these could only be used with the authorization of the Food and Drug Administration and the hospitals involved. "So inaayos ata nila para magkaroon ng better access similar to the EUL, EUA system na mabigyan 'yan ng mga new drugs lalo na kung maganda ang efficacy nila katulad ng sa vaccines," Herbosa said.To date, the Food and Drug Administration has only authorized ronapreve as treatment against the respiratory disease.
Philippine health authorities are also using molnupiravir, remdesivir, tocilizumab and baricitinib as COVID-19 investigational drugs.
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
DOH: 25 children experience adverse reactions after getting COVID-19 jabTwenty-five children with comorbidities aged 12 to 17 experienced adverse reactions after receiving a COVID-19 vaccine, the Department of Health (DOH) said.
Read more »
DOH responds to latest PH dismal COVID-19 resilience ranking in Bloomberg studyThe Department of Health (DOH) said it never lost its focus in responding to the coronavirus disease (COVID-19) pandemic as the Philippines remained at the bottom of an international report in terms of resilience and response to the current health crisis.
Read more »
DOH reports over 3,000 new Covid-19 cases, recoveriesTHE Department of Health (DOH) announced Thursday, October 28, 3,694 new cases of coronavirus disease (Covid-19) that brought the country’s total...
Read more »
DOH to issue policy allowing hospitals to procure investigational drugs for COVID-19An administrative order will soon be released by the Department of Health (DOH) in order to allow hospitals to procure investigational drugs for COVID-19.
Read more »
DOH: Hospitals can buy COVID investigational drugs soonThe Department of Health is set to release a policy allowing hospitals to procure investigational drugs for the treatment of COVID-19.
Read more »
Additional tocilizumab supply may arrive by November — DOHAn additional supply of COVID-19 investigational drug tocilizumab may arrive by the second week of November, the Department of Health (DOH) said Friday.
Read more »